Artificial extracellular matrices composed of collagen I and high-sulfated hyaluronan promote phenotypic and functional modulation of human pro-inflammatory M1 macrophages
Source abstract
Abstract
The sequential phases of biomaterial integration and wound healing require different macrophage functions mediated by distinct macrophage subsets. During the initial phase of healing, pro-inflammatory M1 macrophages (MΦ1) are required to clear the wound from microbes and debris; however, their unopposed, persistent activation often leads to disturbed integration of biomaterials and perturbed wound healing. Here we investigated whether pro-inflammatory macrophage functions are affected by immunomodulatory biomaterials based on artificial extracellular matrices (aECM). To address this issue, we tested the capacity of two-dimensional aECM consisting of collagen I and hyaluronan or sulfated derivatives of hyaluronan to affect functions of in vitro polarized human pro-inflammatory MΦ1. The aECM containing high-sulfated hyaluronan substantially decreased inflammatory macrophage functions, including pathogen uptake and release of the pro-inflammatory cytokines tumor necrosis factor alpha and interleukin-12 due to impaired activation of nuclear factor "kappa-light-chain-enhancer" of activated B-cells. Moreover, these macrophages secreted immunregulatory IL-10 and showed reduced activity of the transcription factors signal transducer and activator of transcription 1 and interferon-regulating factor 5, both controlling macrophage polarization to MΦ1 subsets. Our data reveal that the collagen I matrix containing high-sulfated hyaluronan possesses immunomodulating properties and dampens inflammatory macrophage activities by impeding signaling pathways crucial for polarization of pro-inflammatory MΦ1. We therefore suggest this aECM as a promising coating for biomaterials to modulate inflammatory macrophage functions during the healing response and recommend its further testing as a three-dimensional construct and in in vivo models.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Wound Healing and Treatments · Proteoglycans and glycosaminoglycans research · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
2. Nonresolving inflammation10.1016/j.cell.2010.02.029 ↗
3. Wound healing: an overview of acute, fibrotic and delayed healing10.2741/1184 ↗
4. A review on macrophage responses to biomaterials10.1088/1748-6041/1/1/R01 ↗
5. Exploring the full spectrum of macrophage activation10.1038/nri2448 ↗
6. Role of macrophages in normal wound healing: an overview10.12968/jowc.2009.18.8.43636 ↗
7. Inflammation in wound repair: molecular and cellular mechanisms10.1038/sj.jid.5700701 ↗
8. Macrophage activation and polarization10.2741/2692 ↗
9. Immune responses to implants – a review of the implications for the design of immunomodulatory biomaterials10.1016/j.biomaterials.2011.05.078 ↗
10. The extracellular matrix: not just pretty fibrils10.1126/science.1176009 ↗
11. Glycomics approach to structure–function relationships of glycosaminoglycans10.1146/annurev.bioeng.8.061505.095745 ↗
12. Interactions between extracellular matrix and growth factors in wound healing10.1111/j.1524-475X.2009.00466.x ↗
13. Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation10.1096/fj.05-4682rev ↗
14. Heparin and heparan sulfate bind interleukin-10 and modulate its activity10.1182/blood.V96.5.1879 ↗
15. Sulfation patterns of glycosaminoglycans encode molecular recognition and activity10.1038/nchembio810 ↗
16. Hyaluronan fragments: an information-rich system10.1016/j.ejcb.2006.05.009 ↗
17. Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4)10.1021/bm9008827 ↗
18. Sulfated hyaluronan and chondroitin sulfate derivatives interact differently with human transforming growth factor-beta1 (TGF-beta1)10.1016/j.actbio.2012.03.021 ↗
19. Growth promoting substrates for human dermal fibroblasts provided by artificial extracellular matrices composed of collagen I and sulfated glycosaminoglycans10.1016/j.biomaterials.2011.08.025 ↗
20. Artificial extracellular matrices composed of collagen I and sulfated hyaluronan with adsorbed transforming growth factor beta1 promote collagen synthesis of human mesenchymal stromal cells10.1016/j.actbio.2011.10.026 ↗
21. Hintze V, Miron A, Möller S, Schnabelrauch M, Heinemann S, Worch H. et al. Artificial extracellular matrices of collagen and sulfated hyaluronan enhance the differentiation of human mesenchymal stem cells in the presence of dexamethasone. J Tissue Eng Regen Med 2012;accepted:.10.1002/term.1528 ↗
22. Dermal fibroblasts promote the migration of dendritic cells10.1038/jid.2009.253 ↗
23. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation10.1189/jlb.0105015 ↗
24. The chemokine system in diverse forms of macrophage activation and polarization10.1016/j.it.2004.09.015 ↗
25. NF-kappaB: a key role in inflammatory diseases10.1172/JCI11830 ↗
26. Integrating cell-signalling pathways with NF-kappaB and IKK function10.1038/nrm2083 ↗
27. Transcriptional regulation of macrophage polarization: enabling diversity with identity10.1038/nri3088 ↗
28. An antiinflammatory role for IKKbeta through the inhibition of “classical” macrophage activation10.1084/jem.20080124 ↗
29. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation10.4049/jimmunol.178.8.5245 ↗
30. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses10.1038/ni.1990 ↗
31. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences10.4049/jimmunol.175.1.342 ↗
32. Clinging to life: cell to matrix adhesion and cell survival10.1007/s10555-005-5134-3 ↗
33. Clearance of apo Nph induces an immunosuppressive response in pro-inflammatory type-1 and anti-inflammatory type-2 MPhi10.1080/08916930902828080 ↗
34. Inhibition of granulocyte-macrophage colony-stimulating factor (GM-CSF) activity by suramin and suramin analogues is correlated to interaction with the GM-CSF nucleotide-binding site
35. Differential roles of macrophages in diverse phases of skin repair10.4049/jimmunol.0903356 ↗
36. Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials10.1016/j.actbio.2011.11.031 ↗
37. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration10.1096/fj.01-0776com ↗
38. Accelerated wound healing phenotype in interleukin 12/23 deficient mice10.1186/1476-9255-8-39 ↗
39. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway10.4049/jimmunol.176.9.5598 ↗
40. Wound healing in MIP-1alpha(−/−) and MCP-1(−/−) mice10.1016/S0002-9440(10)61717-8 ↗
41. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice10.1096/fj.00-0073com ↗
42. Inducing healing-like human primary macrophage phenotypes by 3D hydrogel coated nanofibres10.1016/j.biomaterials.2012.02.050 ↗
43. Blakney · J Biomed Mater Res A · 2012 · 100 · 137510.1002/jbm.a.34104 ↗